Transport
Whidbey Island Public Hospital District
Whidbey Island Public Hospital District was paid $31.48M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoWHIDBEY ISLAND PUBLIC HOSPITAL DISTRICT
COUPEVILLE, WA 98239
COUPEVILLE, WA 98239
33aNPI1710927231assigned 06/07/2006
33bProvider typeAmbulance
28Total paid$31.48M
24GClaims436,056
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulance providers in Washington
Rank by total paid#1 of 13
Median peer was paid$4.95M
This provider vs. median6.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 72,318 | $4.71M | |
| 2019 | 71,562 | $4.18M | |
| 2020 | 58,504 | $3.81M | |
| 2021 | 63,296 | $4.20M | |
| 2022 | 61,782 | $5.22M | |
| 2023 | 61,980 | $5.34M | |
| 2024incomplete | 46,614 | $4.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 19,980 | 17,434 | $5.05M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 35,359 | 31,295 | $4.79M |
| A0999 | Unlisted ambulance service | 12% | 5,114 | 4,145 | $3.68M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.5% | 2,431 | 2,291 | $2.06M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 2,695 | 2,346 | $1.76M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 16,261 | 5,735 | $964K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.3% | 3,488 | 3,223 | $717K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.2% | 6,811 | 2,641 | $708K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 8,215 | 7,815 | $650K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 2,125 | 1,984 | $526K |
| A0425 | Ground mileage, per statute mile | 1.5% | 12,621 | 8,508 | $481K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 5,916 | 5,226 | $443K |
170 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 23,155 | $417K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 5,609 | $412K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 3,602 | $398K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.2% | 1,303 | $389K |
| A0429 | Emergency ambulance ride, basic life support | 1.2% | 7,489 | $380K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 3,385 | $369K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 34,777 | $338K |
| A0427 | Emergency ambulance ride, advanced life support | 1.1% | 3,887 | $337K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 24,908 | $317K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,643 | $281K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,346 | $279K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 325 | $278K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,080 | $266K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,757 | $237K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,190 | $208K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,392 | $200K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,389 | $193K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,810 | $188K |
| 96376 | <1% | 2,075 | $173K | |
| 83690 | <1% | 13,086 | $171K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,107 | $160K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,986 | $153K |
| 80061 | Lipid panel | <1% | 6,028 | $143K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,565 | $135K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,655 | $118K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 864 | $117K |
| 80050 | General health panel | <1% | 1,169 | $116K |
| 76830 | Ultrasound, transvaginal | <1% | 782 | $115K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 331 | $111K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,012 | $94K |
| 87481 | <1% | 901 | $93K | |
| 97161 | <1% | 998 | $86K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 502 | $84K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 864 | $84K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,151 | $83K |
| 87631 | <1% | 681 | $81K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,584 | $75K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,584 | $74K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,690 | $73K |
| 73630 | <1% | 908 | $66K | |
| 73610 | <1% | 858 | $66K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 496 | $66K |
| 84484 | <1% | 3,191 | $65K | |
| 81001 | <1% | 7,112 | $65K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,988 | $58K |
| 81025 | <1% | 4,574 | $57K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,712 | $54K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,014 | $53K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 598 | $51K |
| 87070 | <1% | 2,904 | $45K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,127 | $45K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 366 | $43K |
| 80306 | <1% | 2,130 | $38K | |
| 73030 | <1% | 491 | $37K | |
| 81003 | <1% | 5,179 | $36K | |
| 85610 | <1% | 2,757 | $32K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 826 | $31K |
| 82728 | <1% | 1,326 | $30K | |
| 72100 | <1% | 253 | $30K | |
| 83735 | <1% | 2,932 | $29K | |
| 84439 | <1% | 1,635 | $29K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,041 | $29K |
| 73110 | <1% | 364 | $27K | |
| 86803 | <1% | 1,126 | $27K | |
| 76801 | <1% | 176 | $26K | |
| 84466 | <1% | 1,357 | $26K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 222 | $25K |
| 83880 | <1% | 637 | $24K | |
| G0378 | Hospital observation service, per hour | <1% | 93 | $24K |
| 73130 | <1% | 287 | $23K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,255 | $23K |
| 86850 | <1% | 829 | $22K | |
| 87430 | <1% | 1,067 | $22K | |
| 82570 | <1% | 1,212 | $21K | |
| 86900 | <1% | 922 | $21K | |
| 87181 | <1% | 2,234 | $20K | |
| 82607 | <1% | 847 | $19K | |
| 85651 | <1% | 1,323 | $19K | |
| 87077 | <1% | 1,281 | $17K | |
| 85027 | <1% | 1,864 | $17K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,426 | $16K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 537 | $15K |
| 83605 | <1% | 940 | $15K | |
| 83540 | <1% | 1,389 | $14K | |
| 84153 | <1% | 391 | $13K | |
| 86140 | <1% | 1,272 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 566 | $13K |
| 86901 | <1% | 923 | $13K | |
| 84702 | <1% | 383 | $11K | |
| 87276 | <1% | 681 | $10K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 334 | $10K |
| 73564 | <1% | 73 | $10K | |
| 81514 | <1% | 173 | $9K | |
| 87275 | <1% | 681 | $9K | |
| 76642 | <1% | 116 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 246 | $8K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,520 | $8K |
| 80143 | <1% | 173 | $8K | |
| 90715 | <1% | 126 | $7K | |
| 82043 | <1% | 758 | $7K | |
| 73562 | <1% | 104 | $7K | |
| 97162 | <1% | 74 | $7K | |
| 87205 | <1% | 912 | $7K | |
| 12001 | <1% | 76 | $6K | |
| 86592 | <1% | 708 | $6K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 38 | $6K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 201 | $6K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 272 | $6K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $5K |
| 73140 | <1% | 53 | $5K | |
| 87340 | <1% | 240 | $5K | |
| 93971 | <1% | 36 | $5K | |
| 87040 | <1% | 251 | $5K | |
| 82550 | <1% | 426 | $5K | |
| 82746 | <1% | 198 | $5K | |
| 84481 | <1% | 163 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $4K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 120 | $4K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 119 | $4K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 12 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 554 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 139 | $3K |
| 93975 | <1% | 13 | $3K | |
| J3490 | Unclassified drugs | <1% | 123 | $3K |
| 96367 | <1% | 73 | $3K | |
| 85730 | <1% | 165 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 93 | $2K |
| 84100 | <1% | 232 | $2K | |
| 97116 | <1% | 62 | $2K | |
| 85379 | <1% | 51 | $2K | |
| 10060 | <1% | 14 | $2K | |
| 84550 | <1% | 132 | $2K | |
| 72070 | <1% | 16 | $2K | |
| 82803 | <1% | 58 | $1K | |
| 86696 | <1% | 38 | $1K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 52 | $957.56 |
| 86695 | <1% | 38 | $858.76 | |
| 83615 | <1% | 66 | $802.74 | |
| 87797 | <1% | 24 | $798.90 | |
| 84703 | <1% | 41 | $741.04 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 31 | $733.96 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 119 | $680.24 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 14 | $636.23 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $612.01 |
| 82950 | <1% | 50 | $602.90 | |
| 82150 | <1% | 40 | $584.83 | |
| 86038 | <1% | 28 | $584.15 | |
| 86787 | <1% | 29 | $581.62 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 59 | $522.20 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 52 | $476.48 |
| 94664 | <1% | 12 | $401.49 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 58 | $345.42 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $312.49 |
| 82009 | <1% | 15 | $310.66 | |
| 87046 | <1% | 24 | $290.68 | |
| 80320 | <1% | 85 | $283.68 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 70 | $252.44 |
| 86762 | <1% | 12 | $241.11 | |
| 36416 | <1% | 31 | $205.44 | |
| 87045 | <1% | 12 | $145.34 | |
| 83721 | <1% | 12 | $115.10 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 19 | $100.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 73 | $93.06 |
| 84436 | <1% | 12 | $91.81 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 21 | $47.99 |
| 80329 | <1% | 42 | $47.04 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 20 | $34.16 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 19 | $28.24 |
| A9270 | Non-covered item or service | <1% | 22,065 | $17.52 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, GARTH (COO)
Parent organizationWHIDBEY ISLAND PUBLIC HOSPITAL DISTRICT
| Provider | Location | Paid |
|---|---|---|
| Whidbey Island Public Hospital District | Oak Harbor, WA | $3.04M |
| Whidbey Island Public Hospital District | Oak Harbor, WA | $2.73M |
| Whidbey Island Public Hospital District | Clinton, WA | $1.61M |
| Whidbey Island Public Hospital District | Freeland, WA | $975K |
| Whidbey Island Public Hospital District | Coupeville, WA | $561K |
| Whidbey Island Public Hospital District | Oak Harbor, WA | $68K |
| Whidbey Island Public Hospital District | Coupeville, WA | $21K |
| Whidbey Island Public Hospital District | Coupeville, WA | $18K |
| Whidbey Island Public Hospital District | Coupeville, WA | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.